A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2007
11/29/2007	US20070275873 Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting
11/29/2007	US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007	US20070275437 Antibodies to G protein-coupled receptor
11/29/2007	US20070275099 MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
11/29/2007	US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007	US20070275079 Antigen-Containing Microspheres for the Treatment of Allergies
11/29/2007	US20070275071 Use of Microparticles for Antigen Delivery
11/29/2007	US20070275069 Hydrophobic biomolecular structure
11/29/2007	US20070275049 Anti-tumor molecular vacine and method of making thereof
11/29/2007	US20070275048 Liposome composition for delivery of a therapeutic agent to eyes
11/29/2007	US20070275024 Starch Films and Uses Thereof
11/29/2007	US20070275019 Vaccines directed to cancer-associated carbohydrate antigens
11/29/2007	US20070275018 Relates to gene NcSAG4, the RNA messenger of said gene, the oligonucleotides designed based on the nucleotide sequence thereof, and to protein NcSAG4 encoded thereby, and expression vectors, for the purpose of diagnosis and vaccination for the prevention of neosporosis
11/29/2007	US20070275017 Identification of Antigenically Important Neisseria Antigens by Screening Insertional Mutant Libraries with Antiserum
11/29/2007	US20070275016 Kennel cough vaccine
11/29/2007	US20070275015 Sequences encoding the pre-membrane and envelope proteins of West Nile virus having an attenuating mutation and the capsid and non-structural proteins of Yellow Fever virus; chimeric flavivirus
11/29/2007	US20070275014 Influenza antigens, vaccine compositions, and related methods
11/29/2007	US20070275013 Vaccine and Method of Use
11/29/2007	US20070275012 Pharmaceutical Compositions for Therapeutic Use
11/29/2007	US20070275011 Inducible Bacterial Expression System Utilising Sspa Promoter from Salmonella
11/29/2007	US20070275010 Mva Vaccines
11/29/2007	US20070275007 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer
11/29/2007	US20070275006 Iridoid glycoside composition
11/29/2007	US20070275005 Use of Lipopeptides for Activating T Lymphocytes Through the Skin
11/29/2007	US20070275004 Group b streptococcus antigens
11/29/2007	US20070275003 polynucleotides that code for HPV E6/E7 fusion proteins, having mutagenesis points, used to generate immune responses against HPV and prevent or treat cervical cancer
11/29/2007	US20070275002 Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
11/29/2007	US20070275001 Rational Design and Engineering of Proteins and Peptides for Immunomodulation
11/29/2007	US20070275000 Tick Engorgement Factor Proteins
11/29/2007	US20070274999 Method of treating disorders using platelet glycoprotein Ib alpha fusion polypeptides
11/29/2007	US20070274998 Novel Bispecific Molecules For Use In Therapy And Diagnosis
11/29/2007	US20070274997 Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
11/29/2007	US20070274996 IL-4R antagonists; allergies and asthma
11/29/2007	US20070274995 Cardiotrophin-1 compositions and methods for the treatment of tumor
11/29/2007	US20070274994 Virulence-Associated Adhesins
11/29/2007	US20070274993 Immunocompetent Cell Activation Inhibitor and Use Thereof
11/29/2007	US20070274991 Treatment of tumors expressing mutant EGF receptors
11/29/2007	US20070274990 Novel Therapeutic Targets in Cancer
11/29/2007	US20070274989 Methods and Compositions for the Prevention and Treatment of Sepsis
11/29/2007	US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007	US20070274987 Expression of the cysteine protease legumain in vascular and inflammatory diseases
11/29/2007	US20070274986 Compositions comprising anti-CCR5 antibody
11/29/2007	US20070274985 Antibody
11/29/2007	US20070274984 Methods for treating autoimmune diseases using a taci-ig fusion molecule
11/29/2007	US20070274983 Nutritional Composition Comprising Immunoglobulins and Oligosaccharides
11/29/2007	US20070274982 Anti-EpCam Immunoglobulins
11/29/2007	US20070274981 Fibroblast Growth Factor Receptor-1 Inhibitors and Methods of Treatment Thereof
11/29/2007	US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007	US20070274948 Methods of Therapy for Chronic Lymphocytic Leukemia
11/29/2007	US20070274915 Modulation Of Anergy And Methods For isolating Anergy-Modulating Compounds
11/29/2007	US20070274912 Histone Modifications as Binary Switches Controlling Gene Expression
11/29/2007	DE68907430C5 Cytotoxische Therapie. Cytotoxic therapy.
11/29/2007	CA2670804A1 Immunological composition
11/29/2007	CA2654467A1 Prostate epithelial androgen receptor suppresses prostate growth and tumor invasion
11/29/2007	CA2654460A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections through interference with opuc operon interaction with trap
11/29/2007	CA2652886A1 High affinity human and humanized anti-.alpha.5.beta.1 integrin function blocking antibodies with reduced immunogenicity
11/29/2007	CA2652870A1 Treatment of cancer with anti-il-1a antibodies
11/29/2007	CA2652768A1 Inhibitors of progastrin-induced repression of icat for treating and/or preventing colorectal cancer, adenomatous polyposis or metastasis displaying progastrin-secreting cells andcells in which the beta-catenin/tcf-4-mediated transcriptional pathway is constitutively active
11/29/2007	CA2652600A1 Use of cathepsin k antagonists in bone production
11/29/2007	CA2652595A1 Defective interfering virus
11/29/2007	CA2652426A1 Immunogenic compositions
11/29/2007	CA2649722A1 Use of an antibody
11/29/2007	CA2640671A1 Engineered antibody-stress protein fusions
11/29/2007	CA2637988A1 Anti-fgf19 antibodies and methods using same
11/28/2007	EP1860192A1 Compositions and methods for treating intracellular diseases
11/28/2007	EP1860191A2 Combination neisserial compositions
11/28/2007	EP1860187A1 Apo-2 receptor
11/28/2007	EP1860119A1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
11/28/2007	EP1860117A2 Anti-bacterial vaccine compositions
11/28/2007	EP1859793A1 Novel combinational use of sulfonamide compound
11/28/2007	EP1859283A1 Use of nt-proanp/nt-probnp ratio for diagnosing cardiac dysfunctions
11/28/2007	EP1859277A2 Treating neurological disorders
11/28/2007	EP1858923A1 A molecule and chimeric molecules thereof
11/28/2007	EP1858917A2 Varicella zoster virus vaccine
11/28/2007	EP1858552A2 Composition comprising human igg2 antibody and a chelating agent
11/28/2007	EP1858551A2 Combination vaccines with whole cell pertussis antigen
11/28/2007	EP1858550A2 Vaccine formulation
11/28/2007	EP1858549A2 Composition comprising the n-terminal region of leishmania histone h2b, use thereof for inducing an immune response
11/28/2007	EP1858548A2 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
11/28/2007	EP1858547A1 Immunogenic compositions
11/28/2007	EP1858541A2 Use of modulators of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism
11/28/2007	EP1858530A2 Immunostimulating polyphosphazene compounds
11/28/2007	EP1858487A2 Chemically defined stabiliser composition
11/28/2007	EP1601689B1 Purification process for bacterial cytolysin
11/28/2007	EP1539238B1 Monoclonal antibodies and complementarity-determining regions binding to ebola glycoprotein
11/28/2007	EP1425275B1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, and process for dna hybridizatioon detection using the polymer
11/28/2007	EP1412486B1 Method for virus propagation
11/28/2007	EP1338198B1 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse
11/28/2007	EP1326638B1 Vaccines against cancers
11/28/2007	EP1084260B1 Caspase-9 deficient animals and the use thereof
11/28/2007	EP0977844B1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
11/28/2007	EP0957934B1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein
11/28/2007	EP0910387B1 Apoptosis associated protein bbk
11/28/2007	CN101080487A Mature dendritic cell compositions and methods for culturing same
11/28/2007	CN101080421A Antibody and utilization of the same
11/28/2007	CN101080239A Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis
11/28/2007	CN101080227A Combinations of therapeutic agents for treating cancer
11/28/2007	CN101077887A Human accelerated haematogenous cell proliferated cytokine, preparation method and use thereof
11/28/2007	CN101077416A Methods for vaccinating against malaria
11/28/2007	CN100351385C Herpes viruses for immune modulation

1 ... 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 ... 1823